Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japanese Pediatricians Want 1 Million Children Atop H1N1 Vaccine List

This article was originally published in PharmAsia News

Executive Summary

A Japanese physicians group urged the government to give about 1 million children priority for receiving the H1N1 flu vaccine when it becomes available. The Japan Pediatric Society said the million children are considered high-risk with cancer, kidney failure or asthma or serious physical or mental disabilities. The society said the priority list should include another 5.5 million preschool children and parents of infants under a year old. The pediatricians also urged the government to provide those shots for free instead of charging recipients for each inoculation, as planned. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC072601

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel